Our team at NYU Langone’s Division of Colon and Rectal Surgery conducts research to develop innovative surgical techniques and devices to enhance treatment for colon and rectal cancer and functional bowel disorders. Our goal is to improve survival, quality of life, and clinical outcomes for our patients.

Our research helps people preserve ileal pouch-anal anastomosis (J-pouch) function and avoid permanent ileostomy for conditions such ulcerative colitis. We conduct clinical trials of advanced treatment options such as new medications to maintain remission in people who have inflammatory bowel disease (IBD).

Our current clinical trials include the following:

• A Phase II–III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection with Total Mesorectal Excision (PROSPECT)
• A Phase III Randomized, Double-Blind Parallel Group, Placebo-Controlled, International, Multicenter Study to Assess Efficacy and Safety of Cx601 Adult Allogeneic Expanded Adipose-Derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula
• Efficacy and Safety of LifeSeal^™ Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study

Our clinicians and scientists conduct clinical trials and research studies to investigate new treatments for people who have colorectal conditions. Browse all current clinical trials at NYU Langone and search trials by condition or investigator.

Colon and Rectal Surgery Faculty Publications